(Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 93.37%-60.97K | -110.62%-173.28K | 58.16%-286.06K | 82.21%-434.57K | -24.62%-463.06K | -23.74%-919K | 225.32%1.63M | -2,446.62%-683.72K | -2,386.38%-2.44M | -1,057.61%-371.59K |
Net income from continuing operations | 84.89%-194.25K | 42.55%-300.26K | 227.51%698.99K | -228.13%-13.16M | -894.56%-10.8M | -48.25%-1.29M | 74.32%-522.67K | -2,504.10%-548.16K | -498.86%-4.01M | -90.98%-1.09M |
Operating gains losses | --220 | --0 | ---1.05M | -64.17%20.69K | --0 | --0 | ---- | ---- | 381.30%57.76K | --84.51K |
Depreciation and amortization | -99.69%1.37K | -99.67%1.38K | -99.44%1.39K | 213.05%1.63M | 33.13%523.53K | 321.11%447.35K | 1,761.90%413.75K | --248.59K | --521.71K | --393.26K |
Asset impairment expenditure | ---- | ---- | ---- | --11.5M | --10.04M | ---- | ---- | ---- | --0 | --0 |
Remuneration paid in stock | --0 | --0 | --0 | -46.76%769.25K | -11.70%118.68K | 18.27%233.43K | -71.67%315.36K | --101.79K | 180.03%1.44M | -73.95%134.4K |
Deferred tax | ---- | ---- | ---- | -732.71%-891K | ---- | ---- | ---- | ---- | ---107K | ---- |
Other non cashItems | ---- | ---- | ---- | 1,019.06%300.74K | 214.46%106.81K | 1,350.99%4.38K | 156.85%4.37K | 62,669.49%185.17K | 2,261.51%26.87K | --33.97K |
Change In working capital | 107.39%131.69K | -91.03%125.6K | 109.11%61.12K | -62.24%-611.98K | 64.68%441.38K | -991.69%-1.78M | 394.12%1.4M | -10,914.38%-671.11K | -993.23%-377.2K | 3,498.99%268.02K |
-Change in receivables | 104.16%17.12K | --0 | 98.02%-16.8K | -1,157.22%-1.81M | -838.91%-1.29M | -7,073.56%-411.26K | --747.48K | ---847.09K | ---143.58K | ---137.85K |
-Change in inventory | --0 | ---- | ---- | ---101.58K | --1.22K | ---6.16K | ---- | ---- | --0 | --0 |
-Change in prepaid assets | -100.79%-5.61K | 97.68%-2.81K | -104.61%-6.78K | 485.69%906.11K | 2,107.24%173.59K | 974.03%706.51K | 58.39%-120.9K | 10,060.95%146.92K | ---234.93K | ---8.65K |
-Change in payables and accrued expense | 66.29%120.18K | 29.43%128.41K | 191.46%84.69K | 148,057.71%1.95M | 322.35%1.75M | 132.37%72.27K | 153.54%99.21K | 729.21%29.06K | -96.88%1.32K | 5,466.21%414.52K |
-Change in other working capital | ---- | ---- | ---- | ---1.56M | ---189.83K | ---2.14M | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 93.37%-60.97K | -110.62%-173.28K | 58.16%-286.06K | 82.21%-434.57K | -24.62%-463.06K | -23.74%-919K | 225.32%1.63M | -2,446.62%-683.72K | -2,386.38%-2.44M | -1,057.61%-371.59K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | 54.94%-169.7K | -183.37%-1.42M | 120.00%43.45K | 58.91%-162.46K | -931.98%-925.18K | -376.62K | -501.39K | -217.24K |
Capital expenditure reported | ---- | ---- | ---- | 29.79%-322.09K | ---- | ---- | ---- | ---- | ---458.75K | ---- |
Net PPE purchase and sale | --0 | ---- | ---- | -2,357.90%-383.14K | -806.69%-22.37K | -511.13%-80.19K | ---- | ---- | ---15.59K | ---2.47K |
Net intangibles purchas and sale | --0 | ---- | ---- | ---- | ---- | 94.89%-19.52K | ---- | ---- | ---- | ---- |
Net business purchase and sale | --0 | --0 | 54.94%-169.7K | -743.50%-715.58K | --61.94K | ---62.75K | -404.09%-338.15K | ---376.62K | --111.2K | --0 |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---138.26K | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | --0 | 54.94%-169.7K | -183.37%-1.42M | 120.00%43.45K | 58.91%-162.46K | -931.98%-925.18K | ---376.62K | ---501.39K | ---217.24K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 99.56%-1.35K | -71.76%500K | -36.40%1.82M | 61.34K | 1,717.14%295.45K | -111.72%-304.68K | 608.79%1.77M | 536.63%2.87M | 0 |
Net issuance payments of debt | --0 | ---- | ---- | 222.55%47.48K | --61.34K | -13.71%-44.05K | ---- | ---- | -358.27%-38.74K | --0 |
Net common stock issuance | --0 | --0 | -69.24%500K | -31.04%1.96M | --0 | --339.5K | --0 | 363.72%1.63M | 329.68%2.85M | --0 |
Proceeds from stock option exercised by employees | --0 | --0 | --0 | 163.64%145K | --0 | --0 | --0 | --145K | --55K | --0 |
Net other financing activities | ---- | ---- | ---- | ---334.88K | --0 | --0 | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | 99.56%-1.35K | -71.76%500K | -36.40%1.82M | --61.34K | 1,717.14%295.45K | -111.72%-304.68K | 608.79%1.77M | 536.63%2.87M | --0 |
Net cash flow | ||||||||||
Beginning cash position | -94.29%78.49K | -74.93%236.74K | -27.62%194.31K | -23.77%268.46K | -20.22%675.27K | -29.51%1.37M | 64.18%944.15K | -23.77%268.46K | 118,076.85%352.17K | 32.34%846.45K |
Current changes in cash | 92.24%-60.97K | -143.51%-174.63K | -93.77%44.24K | 58.08%-32.95K | 39.15%-358.28K | 29.93%-786.01K | -71.52%401.34K | 218.50%710K | -122.34%-78.6K | -104.84%-588.83K |
Effect of exchange rate changes | -115.12%-13.1K | -43.75%16.38K | 94.71%-1.81K | -706.62%-41.2K | -1,231.76%-122.68K | 378.49%86.66K | 185.51%29.13K | ---34.31K | ---5.11K | --10.84K |
End cash Position | -99.34%4.43K | -94.29%78.49K | -74.93%236.74K | -27.62%194.31K | -27.62%194.31K | -20.22%675.27K | -29.51%1.37M | 64.18%944.15K | -23.77%268.46K | -23.77%268.46K |
Free cash from | 94.02%-60.97K | -116.59%-173.28K | 58.16%-286.06K | 60.93%-1.14M | -6.87%-481.55K | 10.49%-1.02M | 180.22%1.04M | -2,446.62%-683.72K | -2,869.18%-2.92M | -1,303.67%-450.58K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data